* Streamline Health Solutions Inc STRM.OQ STRM.O is
expected
to show a rise in quarterly revenue when it reports results on
June 8.
* The Atlanta Georgia-based company is expected to report
a
75.9% increase in revenue to $5.19 million from $2.95 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Streamline Health
Solutions Inc is for a loss of 5 cents per share. For the same
quarter last year, the company reported a loss of 7 cents per
share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 14.3%
in the last three months.
* Wall Street's median 12-month price target for Streamline
Health
Solutions Inc is $3, above its last closing price of $1.34.
This summary was machine generated June 6 at 20:41 GMT. All
figures in US dollars unless otherwise stated